Business
Why the MedAdvisor (ASX:MDR) share price is pushing higher today
The MedAdvisor Ltd (ASX: MDR) share price has been a positive performer on Monday morning.
At the time of writing, the medication management platform provider’s shares are up 2.5% to 40 cents.
Why is the MedAdvisor share price pushing higher?
Investors have been buying the company’s shares this morning after the release of a trading update.
According to the release, MedAdvisor’s US subsidiary, Adheris, has been performing better than it anticipated since being acquired on 17 November.
In light of this, the company is expecting Adheris’ revenue to be higher than the guidance it previously provided.
For the period 1 July to the end of November, Adheris achieved revenue of US$14 million. This compares to half year revenue…
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business14 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business13 hours agoHere’s what analysts expect for the BHP share price in the coming year